Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Capricor Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 25 | 29 | +4 |
| Shares | 2.32M | 2.59M | +271.0K (+11.7%) |
| Value | $6.80M | $8.88M | +$2.08M (+30.6%) |
New holders (7)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Selective Wealth Management, Inc. | 213,494 | $732.0K | 0.27% |
| HighTower Advisors, LLC | 21,883 | $75.0K | 0.00% |
| Charles Schwab Investment Management Inc | 14,832 | $51.0K | 0.00% |
| Captrust Financial Advisors | 1,190 | $4.00K | 0.00% |
| Royal Bank of Canada | 500 | $2.00K | 0.00% |
| Citigroup Inc | 20 | $0 | 0.00% |
| Ancora Advisors, LLC | 1,786 | – | – |
Sold out (3)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jump Financial, LLC | 22,800 | $67.0K |
| Tower Research Capital LLC (TRC) | 1,277 | $4.00K |
| Tyler-Stone Wealth Management | 90 | $0 |